miR27a, a fine-tuning molecule, interacts with growth hormone (GH) signaling and ornithine decarboxylase (ODC) via

Ajda Coker-Gurkan1, Kadriye Koyuncu2, Pinar Obakan Yerlikaya3

  • 1Department of Molecular Biology and Genetics, Engineering and Natural Sciences Faculty, Biruni University, Topkapı Campus, 34010, Istanbul, Turkey. ajdaaacoker@gmail.com.

Amino Acids
|November 26, 2021
PubMed

Insights

Growth hormone (GH) mutations impact cell growth and metastasis. MicroRNA-27a (miR27a) regulates polyamine metabolism and epithelial-mesenchymal transition (EMT) by targeting ornithine decarboxylase (ODC), influencing cell proliferation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Autocrine growth hormone (GH) signaling promotes cell proliferation and metastasis.
  • GH gene mutations can impair postnatal growth.
  • Polyamines (PA) are crucial for cell growth and differentiation, and miR27a influences ornithine decarboxylase (ODC) expression.

Purpose of the Study:

  • To investigate the impact of specific GH gene mutations (A13S, F166Δ, T24) on PA metabolism and EMT.
  • To explore the role of miR27a in modulating these effects.

Main Methods:

  • Utilized HEK293 cells expressing wild-type (wt) or mutant GH.
  • Assessed cell viability, proliferation, colony formation, and intracellular PA levels.
  • Manipulated miR27a levels using inhibitors and mimics.
  • Measured STAT5, c-myc, and ODC expression.

Main Results:

  • T24A GH mutation reduced aggressive profiles by decreasing GH signaling, STAT5 activity, and ODC expression.
  • Mutant GH-expressing cells showed lower intracellular PA levels compared to wt GH cells.
  • miR27a inhibition increased proliferation and putrescine levels via ODC and STAT5 upregulation.
  • miR27a mimic transfection decreased GH-mediated proliferation by downregulating ODC, STAT5, and depleting PA.

Conclusions:

  • The T24A GH mutation inhibits GH signaling, reducing cell proliferation and EMT.
  • Autocrine GH-driven proliferation is regulated by miR27a, which controls putrescine levels through ODC targeting.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K